Home LiteratureArticle Details
PMID: 21540331 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor.

Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG, Schertler GF

Abstract

The β(1)-adrenergic receptor (β(1)AR) is a G-protein-coupled receptor whose inactive state structure was determined using a thermostabilized mutant (β(1)AR-M23). However, it was not thought to be in a fully inactivated state because there was no salt bridge between Arg139 and Glu285 linking the cytoplasmic ends of transmembrane helices 3 and 6 (the R(3.50) - D/E(6.30) "ionic lock"). Here we compare eight new structures of β(1)AR-M23, determined from crystallographically independent molecules in four different crystals with three different antagonists bound. These structures are all in the inactive R state and show clear electron density for cytoplasmic loop 3 linking transmembrane helices 5 and 6 that had not been seen previously. Despite significantly different crystal packing interactions, there are only two distinct conformations of the cytoplasmic end of helix 6, bent and straight. In the bent conformation, the Arg139-Glu285 salt bridge is present, as in the crystal structure of dark-state rhodopsin. The straight conformation, observed in previously solved structures of β-receptors, results in the ends of helices 3 and 6 being too far apart for the ionic lock to form. In the bent conformation, the R(3.50)-E(6.30) distance is significantly longer than in rhodopsin, suggesting that the interaction is also weaker, which could explain the high basal activity in β(1)AR compared to rhodopsin. Many mutations that increase the constitutive activity of G-protein-coupled receptors are found in the bent region at the cytoplasmic end of helix 6, supporting the idea that this region plays an important role in receptor activation.

MeSH Terms
Adrenergic beta-1 Receptor Antagonists/metabolism Crystallography, X-Ray Humans Mutant Proteins Protein Binding Protein Conformation Protein Stability Protein Structure, Secondary Receptors, Adrenergic, beta-1/chemistry,metabolism Receptors, G-Protein-Coupled/chemistry
Chemicals
Adrenergic beta-1 Receptor Antagonists Mutant Proteins Receptors, Adrenergic, beta-1 Receptors, G-Protein-Coupled
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Moukhametzianov Rouslan
Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom.
Warne Tony
Edwards Patricia C
Serrano-Vega Maria J
Leslie Andrew G W
Tate Christopher G
Schertler Gebhard F X
References (40)
40 references, click to expand
  1. Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.
    Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94 PMID: 19258456
  2. The repertoire of G-protein-coupled receptors in fully sequenced genomes.
    Mol Pharmacol. 2005 May;67(5):1414-25 PMID: 15687224
  3. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Science. 2008 Nov 21;322(5905):1211-7 PMID: 18832607
  4. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.
    Structure. 2008 Jun;16(6):897-905 PMID: 18547522
  5. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.
    J Mol Biol. 2004 Sep 10;342(2):571-83 PMID: 15327956
  6. PHENIX: building new software for automated crystallographic structure determination.
    Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54 PMID: 12393927
  7. Development and crystallization of a minimal thermostabilised G protein-coupled receptor.
    Protein Expr Purif. 2009 Jun;65(2):204-13 PMID: 19297694
  8. Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors.
    Trends Pharmacol Sci. 2005 Dec;26(12):618-24 PMID: 16260046
  9. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.
    J Biol Chem. 2001 Aug 3;276(31):29171-7 PMID: 11375997
  10. Crystal structure of opsin in its G-protein-interacting conformation.
    Nature. 2008 Sep 25;455(7212):497-502 PMID: 18818650
  11. International Union of Pharmacology. XLVI. G protein-coupled receptor list.
    Pharmacol Rev. 2005 Jun;57(2):279-88 PMID: 15914470
  12. New G-protein-coupled receptor crystal structures: insights and limitations.
    Trends Pharmacol Sci. 2008 Feb;29(2):79-83 PMID: 18194818
  13. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.
    J Am Chem Soc. 2010 Aug 25;132(33):11443-5 PMID: 20669948
  14. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.
    Proc Natl Acad Sci U S A. 1989 Oct;86(19):7321-5 PMID: 2552439
  15. Crystal structure of the ligand-free G-protein-coupled receptor opsin.
    Nature. 2008 Jul 10;454(7201):183-7 PMID: 18563085
  16. Scaling and assessment of data quality.
    Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82 PMID: 16369096
  17. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation.
    J Biol Chem. 1992 Jan 25;267(3):1430-3 PMID: 1346134
  18. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
    Nature. 2007 Nov 15;450(7168):383-7 PMID: 17952055
  19. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.
    Science. 2010 Nov 19;330(6007):1066-71 PMID: 20929726
  20. Refinement of macromolecular structures by the maximum-likelihood method.
    Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55 PMID: 15299926
  21. Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization.
    Biochim Biophys Acta. 2003 Feb 17;1610(1):133-40 PMID: 12586387
  22. Engineering G protein-coupled receptors to facilitate their structure determination.
    Curr Opin Struct Biol. 2009 Aug;19(4):386-95 PMID: 19682887
  23. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
    Trends Pharmacol Sci. 2006 Feb;27(2):92-6 PMID: 16406086
  24. Crystal structure of rhodopsin: A G protein-coupled receptor.
    Science. 2000 Aug 4;289(5480):739-45 PMID: 10926528
  25. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Science. 2007 Nov 23;318(5854):1258-65 PMID: 17962520
  26. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.
    Science. 2010 Nov 19;330(6007):1091-5 PMID: 21097933
  27. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation.
    Proc Natl Acad Sci U S A. 2008 May 27;105(21):7439-44 PMID: 18490656
  28. Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form.
    Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):877-82 PMID: 18192400
  29. A G protein-coupled receptor at work: the rhodopsin model.
    Trends Biochem Sci. 2009 Nov;34(11):540-52 PMID: 19836958
  30. Role of the third intracellular loop for the activation of gonadotropin receptors.
    Mol Endocrinol. 1999 Feb;13(2):181-90 PMID: 9973249
  31. Activation of G protein-coupled receptors.
    Adv Protein Chem. 2007;74:137-66 PMID: 17854657
  32. Structure of bovine rhodopsin in a trigonal crystal form.
    J Mol Biol. 2004 Nov 5;343(5):1409-38 PMID: 15491621
  33. Constitutive activity of muscarinic acetylcholine receptors.
    J Recept Signal Transduct Res. 2006;26(1-2):61-85 PMID: 16595339
  34. Structural biology: A moving story of receptors.
    Nature. 2008 Sep 25;455(7212):473-4 PMID: 18818642
  35. Structure of a beta1-adrenergic G-protein-coupled receptor.
    Nature. 2008 Jul 24;454(7203):486-91 PMID: 18594507
  36. Phaser crystallographic software.
    J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674 PMID: 19461840
  37. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
    Eur J Pharmacol. 2001 Jun 15;421(3):141-7 PMID: 11516429
  38. Conformational complexity of G-protein-coupled receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):397-406 PMID: 17629961
  39. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Nature. 1993 Oct 14;365(6447):649-51 PMID: 8413627
  40. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
    Biochemistry. 2001 Nov 13;40(45):13501-9 PMID: 11695897
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2011-05-17
Epub
2011-00-03
Pages
8228-32
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC3100933
Subset
IM
Grants
Medical Research Council · MC_U105184325 · United Kingdom
Medical Research Council · MC_U105197215 · United Kingdom
Biotechnology and Biological Sciences Research Council · BB/G003653/1 · United Kingdom
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com